Clinical development of VEGF signaling pathway inhibitors in childhood solid tumors.

Clinical development of VEGF signaling pathway inhibitors in childhood solid tumors.

Item
http://www.wikidata.org/entity/Q35599819
Vandetanib successfully controls medullary thyroid cancer-related Cushing syndrome in an adolescent patient.Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: a report from the Children's Oncology Group Phase I Consortium.Aflibercept in pediatric solid tumors: moving beyond the trap.Imaging in childhood cancer: a Society for Pediatric Radiology and Children's Oncology Group Joint Task Force reportPhase I pharmacokinetic and pharmacodynamic study of pazopanib in children with soft tissue sarcoma and other refractory solid tumors: a children's oncology group phase I consortium report.Safety of bevacizumab in patients younger than 4 years of age.Lessons learned from adult clinical experience to inform evaluations of VEGF pathway inhibitors in children with cancer.Inhibition of AGS Cancer Cell Proliferation following siRNA-Mediated Downregulation of VEGFR2.Inhibition of VEGF: a novel mechanism to control angiogenesis by Withania somnifera's key metabolite Withaferin A.The siRNA-Mediated Down-Regulation of Vascular Endothelial Growth Factor Receptor1Emerging and investigational therapies for neuroblastoma.Pilot study of vincristine, oral irinotecan, and temozolomide (VOIT regimen) combined with bevacizumab in pediatric patients with recurrent solid tumors or brain tumors.
P2860

Clinical development of VEGF signaling pathway inhibitors in childhood solid tumors.

Item
http://www.wikidata.org/entity/Q35599819
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Clinical development of VEGF signaling pathway inhibitors in childhood solid tumors.
@ast
Clinical development of VEGF signaling pathway inhibitors in childhood solid tumors.
@en
type
label
Clinical development of VEGF signaling pathway inhibitors in childhood solid tumors.
@ast
Clinical development of VEGF signaling pathway inhibitors in childhood solid tumors.
@en
prefLabel
Clinical development of VEGF signaling pathway inhibitors in childhood solid tumors.
@ast
Clinical development of VEGF signaling pathway inhibitors in childhood solid tumors.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Clinical development of VEGF signaling pathway inhibitors in childhood solid tumors
@en
P2093
P2860
P304
P31
P356
10.1634/THEONCOLOGIST.2011-0148
P433
P478
P50
P577
P5875
P698
P932